CN103320383B - A kind of substratum cultivating rat hair follicle stem cell - Google Patents
A kind of substratum cultivating rat hair follicle stem cell Download PDFInfo
- Publication number
- CN103320383B CN103320383B CN201310290236.9A CN201310290236A CN103320383B CN 103320383 B CN103320383 B CN 103320383B CN 201310290236 A CN201310290236 A CN 201310290236A CN 103320383 B CN103320383 B CN 103320383B
- Authority
- CN
- China
- Prior art keywords
- hair follicle
- follicle stem
- stem cells
- stem cell
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
Abstract
The present invention relates to a kind of substratum cultivating rat hair follicle stem cell.Does is cultivate a substratum for rat hair follicle stem cell, this medium component: 44mlDMEM/F12 nutrient solution, 5mlKSR serum substitute, 500 μ l mycillin mixed solutions, 500 μ l? L-glutaminate, 500 μ l non-essential amino acid, 20ng/ml recombinant human epidermal growth factor, 10ng/ml recombination human basic fibroblast growth factor, 50 μ l hydroxyl ethanols, 10ng/ml hydrocortisone.The present invention is owing to have employed above-mentioned substratum, obtain desirable hair follicle stem cells, genetic modification can be carried out, then as seed cell to this hair follicle stem cells, plant in three-dimensional isinglass spongy tissue support, form into the NEW TYPE OF COMPOSITE artificial skin model with new vascular system.
Description
Technical field
The present invention relates to stem cell, skin tissue engineering field, particularly relate to a kind of substratum cultivating rat hair follicle stem cell.
Technical field
Skin is as the maximum organ of human body, there is sensation, regulate body temperature, secretion and excretion, prevent the multiple effects such as moisture evaporation, wherein topmost function is that it is also immune important component part simultaneously as the barrier of human body and external environment to maintain the stable of environment.Along with socioeconomic development, particularly as the China's manufacturing industry of " world's factory " and the prosperity and development of handicraft, the various wound relating to skin injury is particularly burnt, crush injury, incision etc. also get more and more.Wherein, the widespread skin defect that wound causes usually causes very serious physical disabilities, even dead.The standard treatments of current clinical treatment skin injury is auto-skin grafting, and owing to having without immunological rejection, surviving rate high, it applies very extensive clinically, and achieves good curative effect.But the shortcoming of auto-skin grafting also clearly, owing to being autologous drawing materials, itself being exactly the damage again to patient, greatly adding patient suffering, and have generation skin donor site to infect, the risk of the complication such as disunion.More seriously, for above-mentioned large skin defect, often enough can cause wound repair difficulty for the autologous skin transplanted owing to lacking, have a strong impact on treatment process, even caused death.
Just because of this, scientists attempts to find a kind of ectogenic Graftskin always.As far back as B.C. 1500, dermatoheteroplasty was just used to cover skin wound temporarily.And along with the foundation of organizational engineering and development, skin tissue engineering is risen rapidly, and become the focus studied nearly ten years.Organizational engineering is principle and the method for application project and life science, research biosubstitute, for the subject rebuilding, keep or improve function of organization.At present, the research that foreign applications skin tissue engineering builds artificial skin achieves substantial progress, and the products such as Apligraf, OrCel, Suprathel, Biobrane, OASIS, Integra, Lyphoder are successively ratified to go on the market by united states drug and food control office (FDA) and have been applied in the treatment of clinic skin defect.
But, although existing several artificial skin products above can supply selection of clinical at present, also really facilitate the clinical treatment to large skin defect patient.But, according to the problem run in our clinical application for many years process, in conjunction with bibliographical information, we think that current artificial skin is transplanted and also there is many problems, wherein even comprise and may cause treating " hard defects " that prove an abortion: 1. because above artificial skin product does not all have vasculogenesis ability, cause the artificial skin transplanted not have vascular system to supply nutrition, thus artificial skin is easily necrosed, make graft failure.2. contained in artificial skin product various variant cells easily cause immunological rejection, and often occur the cutaneous necrosis of transplanting clinically, come off, serious even occurs the severe complications such as systemic immune response, and likely spreads disease.3. all people's work skin products all can only recover part anatomical structure and the physiological function of normal skin at present, and cannot regenerate the cutaneous appendages structure with critical function, such as: blood vessel, hair, sweat gland etc.
Hair follicle stem cells is the stem cell that a class is present in raw coal bunker knuckle portion, has the features such as a point voltinism, self and in-vitro multiplication ability are strong.Hair follicle stem cells in vitro culture research shows high clonality, has very high regeneration potential.Because hair follicle stem cells derives from hair, can directly obtain from patient self, quantity is extremely abundant, and without any complication, to patient completely without wound, has now become the focus of skin tissue engineering research.(the TaylorG such as Taylor, LehrerMS, JensenPJ, etal.Involvementoffollicularstemcellsinformingnotonlythe folliclebutalsotheepidermis.Cell, 2000,102 (4): 451-461.) research finds that hair follicle stem cells can not only be differentiated to form hair follicle, but also take part in the forming process of face tissue.The current research result that Stelios etc. deliver proves, containing a large amount of stem cells in hair follicle, is one of source of human stem cell the most easily obtained, and successfully hair follicle stem cells differentiation and development is generated new vascular system.Vascular endothelial growth factor 165 (VEGF165) is one of vascular endothelial growth factor 5 kinds of hypotypes, and its activity is the strongest, and distribution range is the widest, is the Main Subtype played a role in VEGF body.Domestic and international study hotspot is become in recent years around the revascularization gene therapy research centered by VEGF165.
Applicant has applied for a kind of method of VEGF165 genetic modification hair follicle stem cells for this reason, and the method is seed cell with hair follicle stem cells, can increase by rapid, high volume, originate very abundant, reduce immunological rejection when having vitro culture; Utilize VEGF165 gene transfection to modify hair follicle stem cells simultaneously, the new engineered blood vessels system with enlargement and contraction function can be formed, well will solve transplanting artificial skin easily downright bad, the problem that surviving rate is low.
Summary of the invention
Carry out source problem in order to what solve current hair follicle stem cells, the object of this invention is to provide a kind of substratum cultivating rat hair follicle stem cell.Can rapid, high volume amplification during this substratum hair follicle stem cells vitro culture of employing of the present invention.
In order to realize above-mentioned object, present invention employs following technical scheme:
Cultivate a substratum for rat hair follicle stem cell, this medium component is: 44mlDMEM/F12 nutrient solution, 5mlKSR serum substitute, 500 μ l mycillin mixed solutions, 500 μ lL-glutamine, 500 μ l non-essential amino acid, 20ng/ml recombinant human epidermal growth factor, 10ng/ml recombination human basic fibroblast growth factor, 50 μ l hydroxyl ethanols, 10ng/ml hydrocortisone.
The present invention is owing to have employed above-mentioned substratum, obtain desirable hair follicle stem cells, genetic modification can be carried out, then as seed cell to this hair follicle stem cells, plant in three-dimensional isinglass spongy tissue support, form into the NEW TYPE OF COMPOSITE artificial skin model with new vascular system.This model has the advantage of following uniqueness:
1. as stem cell, can increase by rapid, high volume when hair follicle stem cells has vitro culture, long-term in vitro Secondary Culture, the features such as cell function is vigorous, and have very high regeneration and differentiation capability, this will greatly shorten the cultured and amplified in vitro time, improve clinical treatment efficiency;
2. due to the new engineered blood vessels system with enlargement and contraction function can be formed, transplanting artificial skin will well be solved easily downright bad, the problem that surviving rate is low;
3. seed cell-hair follicle stem cells used in this research takes from autologous hair, originates very abundant, is also very easy to obtain, and can not causes any damage and misery to patient;
4. because seed cell takes from autologous tissue, immunological rejection and the problem such as to spread disease will be readily solved;
5. relative to current artificial skin product, this new-type artificial skin will recover and regenerate anatomical structure and the physiological function of normal skin tissue greatly.
Accompanying drawing explanation
Fig. 1-Fig. 3 is that primary hair follicle stem cells climbs out of from Hair Follicle Bulge portion, in nest like, epithelioid cell, arrange tight 40 ×.
Fig. 4 be P1 before purifying for hair follicle stem cells, based on paving stone shape, be mingled with various kinds of cell form 100 ×.
Fig. 5 be P3 after IV Collagen Type VI screening purifying for hair follicle stem cells, in typical paving stone shape 100 ×.
Fig. 6 is rat hair follicle stem cell group sample RNA extracting electrophorogram, swimming lane 1:SD rat hair follicle stem cell group sample RNA.
Fig. 7 is 6 relevant primers and the amplified band of rActb primer in SD rat hair follicle stem cell cDNA;
Swimming lane 1:MarkerDL2000(is respectively 2000,1000,750,500,250,100bp from top to bottom);
The amplification of swimming lane 2:rActb primer in SD rat hair follicle stem cell cDNA (object band 173bp)
The amplification of swimming lane 3:rKrt10 primer in SD rat hair follicle stem cell cDNA (object band 175bp) is primer dimer herein;
The amplification of swimming lane 4:rKrt15 primer in SD rat hair follicle stem cell cDNA (object band 94bp);
The amplification of swimming lane 5:rKrt19 primer in SD rat hair follicle stem cell cDNA (object band 156bp);
The amplification of swimming lane 6:rCD34 primer in SD rat hair follicle stem cell cDNA (object band 146bp);
The amplification of swimming lane 7:rItgb1 primer in SD rat hair follicle stem cell cDNA (object band 72bp);
The amplification of swimming lane 8:rItgb6 primer in SD rat hair follicle stem cell cDNA (object band 188bp).
Fig. 8 is that the expression conditions of 6 goal gene evaluates histogram.
Fig. 9-Figure 11 is the immunofluorescence dyeing of P3 for hair follicle stem cells, is respectively integrin β_1, integrin a6, keratin 15,100 ×.
Figure 12 is the growth curve chart of the P3 hair follicle stem cells after purifying, n=7.
Embodiment
The separation of embodiment 1 hair follicle stem cells, cultivation
1) select SD rat antenna in one week age portion skin, insert 0.25%Dispase enzyme 37 DEG C digestion 2h; Hair follicle is pulled out from subcutis end with tweezers and disposable syringe syringe needle, collect form intact and be in the hair follicle in vegetative period, under microscope, hair follicle is cut into three equal parts, get middle portion, 50mL culturing bottle is put into after PBS rinsing, add DMEM/F12 supplemental medium, after 1 week, Hair Follicle Bulge portion has cell to climb out of, and forms clone.As Fig. 1-Fig. 3.
2) the DMEM/F12 supplemental medium composition described in is brand-new formula: 44mlDMEM/F12 nutrient solution, 5mlKSR serum substitute, 500 μ l mycillin mixed solutions, 500 μ lL-glutamine, 500 μ l non-essential amino acid, 20ng/ml recombinant human epidermal growth factor, 10ng/ml recombination human basic fibroblast growth factor, 50 μ l hydroxyl ethanols, 10ng/ml hydrocortisone;
3) culture condition is 37 DEG C, in 5%CO2 incubator, every 2-3d changes liquid once;
4) digestion condition that goes down to posterity of hair follicle stem cells is: TrypLE
tMexpress (1X), noPhenolRed (Gibco company CAT:12604013), 37 DEG C of digestion 8-10min;
The purifying of embodiment 2 hair follicle stem cells
1) be coated in culture dish by the IV Collagen Type VI of 100 μ g/ml according to the amount of 3ml/100mmdish, room temperature leaves standstill 1h; By the primary cell tryptic digestion of 100mm culture dish, after centrifugal collecting cell, blow and beat into single cell suspension and be inoculated in culture dish, after 20min, by not adherent cell together with nutrient solution sucking-off; The complete culture medium culturing of adherent cell, changes liquid in every 3 days; P2 for repurity once, as Fig. 4-5.
The qualification of embodiment 3 hair follicle stem cells
1) Q-PCR detects: the P3 after sorting purifying carries out Q-PCR detection for hair follicle stem cells.Concrete grammar is as follows:
Concrete grammar is as follows:
1.1) extracted total RNA from the 293T cell of interference plasmid transfection.As Fig. 6
1.1.1) by after broth out, with PBS rinse cell.
1.1.2) in cultured cells in 12 orifice plates, every hole adds 500ulTrizol, at room temperature horizontal positioned 5min, makes lysate be uniformly distributed in cell surface, then makes cell detachment with liquid-transfering gun piping and druming cell.
1.1.3) cell pyrolysis liquid is transferred in centrifuge tube, and repeatedly blows and beats until without obvious sediment in lysate with 1mL rifle head, at room temperature place 5min, nucleic acid-protein mixture is separated completely.
1.1.4) often pipe adds 100 μ l chloroforms, and to turn upside down ep pipe 15s with hand, room temperature leaves standstill 15min, 4 DEG C, 12000rpm, centrifugal 15min.
1.1.5) draw supernatant and move to new 1.5mlep pipe, add the Virahol of equal-volume-20 DEG C of precoolings ,-20 DEG C of precipitation 10min after mixing.
1.1.6) 4 DEG C, after the centrifugal 10min of 12000rpm, remove supernatant, add 75% ethanol of 1ml4 DEG C of precooling, washing precipitation, 4 DEG C, the centrifugal 5min of 10000rpm, abandons supernatant.Thieving paper sucks raffinate, drying at room temperature.
1.1.7) add 10 μ lRNase-free water, to dissolving completely, NanoDrop measures the concentration of RNA.
1.2) RNA reverse transcription becomes cDNA
M-MLV process specifications according to Fermentas company carries out reverse transcription, and system is as follows:
Add in the PCR pipe of RNase-Free (total system 20ul)
| RNA | 1μg |
| Oligo(dT)primer(0.5μg/μl) | 1μl |
| Random primer (0.2μg/μl) | 1μl |
| DEPC· H 2O | 10μl |
Mixing, hatch 10min for 65 DEG C, ice bath at once, then adds
| 5×reaction buffer | 4μl |
| RiboLockTM Ribonuclease inhibitor(20U/μl) | 0.5μl |
| dNTP mix (10mM) | 2μl |
| Reverse Tra Ace | 1μl |
Hatch 60min for 42 DEG C, 70 DEG C of 10min; CDNA is frozen in-20 DEG C or PCR at once.
1.3) RT-PCR preliminary experiment
With the cDNA of reverse transcription for template, with goal gene Auele Specific Primer and internal reference primer amplification goal gene fragment to be detected and house-keeping gene, grope best primer annealing temperature and the template amount of machine on applicable qPCR, if there is the annealing temperature that assorted band should be readjusted in PCR process, until assorted band disappears.
1.4) Q-PCR formally tests
1.4.1) under RT-PCR preliminary experiment finds out the primer annealing temperature of the best and the prerequisite of template amount, use 2 × SYBRGreenMix to prepare PCRMix, go up sample number and the repeat number of machine as required, calculate and prepare PCRMix, system is as follows:
| Composition | Volume |
| 2*SYBR Green Mix | 10ul |
| Primer Mix | 1ul |
| Template | 1ul |
| Ultrapure water | 8ul |
| Cumulative volume | 20ul |
1.4.2) divide and be filled to AXYGENPCR8 connecting leg, microcentrifuge brief centrifugation mixing PCR system.
1.4.3) above-mentioned sample is put into EppendorfRealplex quantitative real time PCR Instrument, SYBRGreen method quantitative fluorescent PCR is to analyze the expression of each gene, and PCR programming is as follows:
PCR reaction can be set as 4 footworks: (the Tm value of annealing temperature in conjunction with primer and the result sets itself of RT-PCR preliminary experiment, melt curve analysis is established from 80 DEG C)
◆ denaturation Cycle1:(1X)
◆ Step1:95.0°Cfor02:00.
◆ PCR circulation Cycle2:(40X)
◆ Step1:95.0°Cfor00:15.
◆ Step2:60.0°Cfor00:15.
◆ Step3:72.0°Cfor00:20.
◆ Step4:83.0°Cfor00:08.
◆ Datacollectionandreal-timeanalysisenabled.
◆ Cycle3:(1X)
◆ Step1:80°Cfor01:00.
◆ solubility curve Cycle4:(31X)
◆ Step1:60.0°C-95.0°Cfor00:10.
◆ Increasesetpointtemperatureaftercycle2by0.5°C
◆ Meltcurvedatacollectionandanalysisenabled.
◆ 1.5) data analysis: the relative quantification carrying out each genetic expression by △ △ Ct method.As Fig. 8, table 1
Table 1 carries out Q-PCR detection for the P3 after sorting purifying for hair follicle stem cells, carries out the relative quantification of each genetic expression by △ △ Ct method.
2) immunofluorescent staining method: by P3 for cell cultures to logarithmic phase, be seeded in after digestion on slide, after adherent culture 2d, sop up nutrient solution, use PBST rinsing, add 4%PFA fixing after, more closed by 5%BSA room temperature.Add primary antibodie integrin β_1 (integrin-β 1) against murine polyclonal antibody (1:100), integrin a6(integrin-a6 respectively) polyclonal antibody (1:50) and keratin 15 (keratin-15) polyclonal antibody (1:100), incubated at room, after PBST washing, label two anti-lucifuge 30min again, add DAPI(1:2000) contaminate core 5min, lucifuge is dried, and uses mountingsolution mounting, as Fig. 9-11.
The multiplication capacity of embodiment 4 hair follicle stem cells
1) growth curve measures: by P3 for hair follicle stem cells, with 1 × 10 after digestion
5the cell concn of/ml is seeded on 24 orifice plates, respectively at 1,2,3,4,5,6,7d carries out cell counting count board counting, 6 multiple holes are set every day, take the mean.Then cell growth curve is drawn, as Figure 12.
Claims (1)
1. cultivate a substratum for rat hair follicle stem cell, it is characterized in that this medium component is: 44mlDMEM/F12 nutrient solution, 5mlKSR serum substitute, 500 μ l mycillin mixed solutions, 500 μ lL-glutamine, 500 μ l non-essential amino acid, 20ng/ml recombinant human epidermal growth factor, 10ng/ml recombination human basic fibroblast growth factor, 50 μ l mercaptoethanols, 10ng/ml hydrocortisone.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310290236.9A CN103320383B (en) | 2013-07-10 | 2013-07-10 | A kind of substratum cultivating rat hair follicle stem cell |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310290236.9A CN103320383B (en) | 2013-07-10 | 2013-07-10 | A kind of substratum cultivating rat hair follicle stem cell |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103320383A CN103320383A (en) | 2013-09-25 |
| CN103320383B true CN103320383B (en) | 2016-04-06 |
Family
ID=49189429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310290236.9A Active CN103320383B (en) | 2013-07-10 | 2013-07-10 | A kind of substratum cultivating rat hair follicle stem cell |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103320383B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106854640A (en) * | 2017-01-16 | 2017-06-16 | 广东万海细胞生物科技有限公司 | A kind of serum free medium of hair follicle stem cells and preparation method thereof |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104195101B (en) * | 2014-09-09 | 2016-04-13 | 武斌 | A kind of Follicular Unit preserves nutrient solution |
| CN105670987B (en) * | 2016-03-21 | 2019-04-02 | 杭州市萧山区中医院 | A kind of hair follicle stem cells are induced to differentiate into the suppressing method of vascular endothelial cell |
| CN113710795A (en) * | 2018-09-26 | 2021-11-26 | 株式会社器官再生工学 | In vitro proliferation method of hair follicle epithelial stem cells |
| CN110923197A (en) * | 2019-11-11 | 2020-03-27 | 浙江卫未生物医药科技有限公司 | Culture medium for hair follicle source cells |
| CN114134116A (en) * | 2021-12-10 | 2022-03-04 | 上海交通大学医学院附属瑞金医院 | Kit for predicting curative effect of chemotherapy drugs of colorectal cancer patient and application thereof |
| CN114317404A (en) * | 2021-12-17 | 2022-04-12 | 上海纳米技术及应用国家工程研究中心有限公司 | Culture medium formula suitable for in-vitro culture of hair follicle stem cells and culture method for in-vitro 3D hair follicle stem cells |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101775366A (en) * | 2010-02-05 | 2010-07-14 | 中国人民解放军第四军医大学 | Preparation method of tissue engineering skin containing hair follicles |
| CN102344906A (en) * | 2010-07-21 | 2012-02-08 | 中国科学院动物研究所 | Hair follicle stem cell separation culture method |
| CN103146644A (en) * | 2013-02-27 | 2013-06-12 | 青岛农业大学 | Technical method for differentiating mouse hair follicle stem cells to primordial germ cells in vitro |
-
2013
- 2013-07-10 CN CN201310290236.9A patent/CN103320383B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101775366A (en) * | 2010-02-05 | 2010-07-14 | 中国人民解放军第四军医大学 | Preparation method of tissue engineering skin containing hair follicles |
| CN102344906A (en) * | 2010-07-21 | 2012-02-08 | 中国科学院动物研究所 | Hair follicle stem cell separation culture method |
| CN103146644A (en) * | 2013-02-27 | 2013-06-12 | 青岛农业大学 | Technical method for differentiating mouse hair follicle stem cells to primordial germ cells in vitro |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106854640A (en) * | 2017-01-16 | 2017-06-16 | 广东万海细胞生物科技有限公司 | A kind of serum free medium of hair follicle stem cells and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103320383A (en) | 2013-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103320383B (en) | A kind of substratum cultivating rat hair follicle stem cell | |
| Choi et al. | Adipogenic differentiation of adipose tissue derived adult stem cells in nude mouse | |
| CN103710297B (en) | The isolation cultivation method of rat hair follicle stem cell | |
| US20090246182A1 (en) | Method for culturing cells derived from the adipose tissue and uses thereof | |
| CN102344906B (en) | Hair follicle stem cell separation culture method | |
| Quattrocelli et al. | Mouse and human mesoangioblasts: isolation and characterization from adult skeletal muscles | |
| CN101864395B (en) | In-vitro inducing differentiation of umbilical cord mesenchymal stem cells into tissue engineering skin seed cells | |
| CN103251649A (en) | Lyophilized powder of human mesenchymal stem cell culture supernatant and preparation method thereof | |
| CN108753708A (en) | A kind of preparation method of Stem Cell Activity factor freeze-dried powder | |
| CN107858329A (en) | The method of fractionation of fatty mescenchymal stem cell and the test solution used from fat | |
| Li et al. | Exogenous Nkx2. 5‑or GATA‑4‑transfected rabbit bone marrow mesenchymal stem cells and myocardial cell co‑culture on the treatment of myocardial infarction in rabbits | |
| CN105647872A (en) | Liver injury targeted mesenchymal stem cell and preparation method and application thereof | |
| US20240034997A1 (en) | Myogenin-expressing fibroblast-like cell (meflc) line and construction method and use thereof | |
| CN109554454A (en) | A method of freeze-dried powder hair regrowth is evaluated by measurement cytokine content | |
| CN108486046A (en) | A kind of stem cell medicine of anti anoxia damage and preparation method thereof with preparing the application in treating acute myocardial infarction drug | |
| CN103468744B (en) | VEGF165 gene modified hair follicle stem cells and preparation method thereof | |
| Chen et al. | MicroRNA-1 regulates the differentiation of adipose-derived stem cells into cardiomyocyte-like cells | |
| CN103215218A (en) | Method for separating and culturing endothelial clone formative cell | |
| Zhang et al. | Effects of RPE‑conditioned medium on the differentiation of hADSCs into RPE cells, and their proliferation and migration | |
| CN101760449B (en) | Method for inducing and acclimating epidermal stem cells into muscle cells | |
| CN103468745B (en) | Preparation method of artificial skin by taking VEGF165 gene modified hair follicle stem cells as seed cells | |
| CN104673744A (en) | In-vitro culturing method for vascular endothelial cells of rat | |
| CN102943063B (en) | Treatment method for improving myocardial cell protective capability and transfer ability of bone marrow mononuclear cells | |
| CN102732478A (en) | Inducer for inducing directional differentiation of umbilical cord mesenchymal stem cells into bladder smooth muscle cells, and preparation and application thereof | |
| CN103487585A (en) | Method used for detecting hair follicle stem cell VEGF165 protein expression by using western blot assay |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |